{"gene":"MRAP","run_date":"2026-04-28T18:30:28","timeline":{"discoveries":[{"year":2005,"finding":"MRAP (melanocortin 2 receptor accessory protein) was identified as an interacting partner of the ACTH receptor (MC2R); mutations in MRAP cause familial glucocorticoid deficiency type 2, and MRAP was shown to interact with MC2R and have a role in trafficking MC2R from the endoplasmic reticulum to the cell surface.","method":"SNP array genotyping (disease mapping), identification of MRAP mutations in FGD2 patients, interaction studies between MRAP and MC2R","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 — foundational discovery paper with genetic mapping plus direct interaction and trafficking data, highly cited","pmids":["15654338"],"is_preprint":false},{"year":2007,"finding":"MRAP forms antiparallel homodimers with a unique dual topology: both N- and C-terminal ends of MRAP face the extracellular side. MRAP homodimers form a stable complex with MC2R at the plasma membrane and are required for MC2R glycosylation, surface localization, and ACTH-stimulated cAMP signaling; without MRAP, MC2R is retained in the endoplasmic reticulum.","method":"Epitope localization with N- and C-terminal antibodies in CHO and adrenal cells, glycosylation mutagenesis to probe membrane topology, co-immunoprecipitation of differentially tagged MRAPs, selective immunoprecipitation of cell-surface MRAP, ELISA and cAMP assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal methods (topology assay, glycosylation mutagenesis, co-IP, functional cAMP assay) in a single rigorous study; first eukaryotic antiparallel homodimer identified","pmids":["18077336"],"is_preprint":false},{"year":2008,"finding":"A short sequence just N-terminal to the transmembrane domain of MRAP is essential for its dual membrane topology; the transmembrane region alone is not sufficient. Deletion or alanine substitution of other N-terminal regions yields MRAP mutants that promote MC2R surface expression but not ACTH binding or receptor signaling, establishing two separable functions of MRAP: (1) facilitating MC2R trafficking and (2) enabling surface receptor binding and cAMP signaling.","method":"Deletion and alanine-substitution mutagenesis of MRAP, surface expression assays, ACTH binding assays, cAMP stimulation assays","journal":"Molecular and cellular endocrinology","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis with multiple functional readouts (trafficking vs. signaling) dissecting two mechanistically distinct MRAP activities","pmids":["19028547"],"is_preprint":false},{"year":2009,"finding":"MRAP and its homologue MRAP2 interact with all five melanocortin receptors (MC1R–MC5R). MRAP/MRAP2 interaction with MC2R promotes surface expression and cAMP signaling, while interaction with MC1R, MC3R, MC4R, and MC5R reduces their responsiveness to NDP-MSH, establishing MRAP and MRAP2 as bidirectional regulators of the MCR family.","method":"Co-immunoprecipitation, surface expression assays (ELISA), cAMP signaling assays, NDP-MSH dose-response experiments in transfected cells","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — reciprocal interaction and functional signaling data across all 5 MCRs with multiple orthogonal methods","pmids":["19329486"],"is_preprint":false},{"year":2009,"finding":"MRAP has opposite effects on MC2R versus MC5R: MRAP promotes MC2R surface expression and traps MC5R intracellularly. MRAP forms stable complexes with both receptors (co-precipitation). MRAP facilitates MC2R homodimerization at the plasma membrane but disrupts MC5R dimerization intracellularly. The regions of MRAP required for effects on MC2R and MC5R differ.","method":"ELISA surface expression assay, confocal microscopy, bimolecular fluorescence complementation (BiFC) for receptor dimerization, co-immunoprecipitation of differentially tagged receptors","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (BiFC, co-IP, ELISA, microscopy) demonstrating mechanistically distinct receptor-specific effects of MRAP","pmids":["19535343"],"is_preprint":false},{"year":2018,"finding":"MRAP deficiency in mice causes neonatal lethality (rescued by maternal corticosterone), isolated glucocorticoid deficiency with normal mineralocorticoid and catecholamine production, small adrenal glands with impaired capsular morphology and cortex zonation, and significantly impaired adrenal progenitor cell differentiation with dysregulation of WNT4/β-catenin and sonic hedgehog pathways.","method":"Mrap-null mouse generation, histology, corticosterone rescue, WNT4/β-catenin and sonic hedgehog pathway analysis in knockout adrenal glands","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 2 — clean knockout model with specific adrenal phenotype and pathway placement (WNT4/SHH), replicated by multiple readouts","pmids":["29879378"],"is_preprint":false},{"year":2023,"finding":"Cryo-EM structure of ACTH-bound MC2R–Gs–MRAP1 complex reveals that MRAP1 has a unique sharp kink at its extracellular region and exerts a 'seat-belt' effect that stabilizes ACTH binding and MC2R activation; mutagenesis validated key contact residues.","method":"Cryo-electron microscopy structure determination, mutagenesis analysis of MRAP1–MC2R interface","journal":"Cell research","confidence":"High","confidence_rationale":"Tier 1 — atomic-resolution cryo-EM structure plus mutagenesis validation, directly revealing the molecular mechanism of MRAP1 action on MC2R","pmids":["36588120"],"is_preprint":false},{"year":2006,"finding":"A novel 7-base deletion in exon 3 of MRAP causing a frameshift and premature stop codon (L31X) was identified in patients with familial glucocorticoid deficiency type 2, confirming that loss-of-function MRAP mutations cause FGD2.","method":"DNA sequencing of MRAP gene in patient fibroblasts and peripheral blood, identification of homozygous frameshift mutation","journal":"The Journal of clinical endocrinology and metabolism","confidence":"Medium","confidence_rationale":"Tier 3 — genetic loss-of-function finding with clinical phenotype, single report confirming MRAP mutation mechanism in FGD2","pmids":["16868047"],"is_preprint":false},{"year":2022,"finding":"MRAP1 interacts with a broad spectrum of GPCRs beyond melanocortin receptors. Protein-protein interactions of MRAP1 with 36 metabolic-related GPCRs were identified; MRAP1/2 modulate surface translocation, constitutive activities, and ligand-stimulated downstream signaling of these GPCRs. Hypothalamic MRAP2 knockdown via AAV-shRNA stimulated body weight gain, and MRAP2 was required for the anorectic effect of CRF acting through CRHR1.","method":"Single-cell transcriptome analysis, co-expression network analysis, protein-protein interaction assays, cell surface translocation assays, cAMP signaling assays, AAV-shRNA knockdown in mouse hypothalamus with body weight and feeding behavior readouts","journal":"Clinical and translational medicine","confidence":"Medium","confidence_rationale":"Tier 2–3 — broad interactome screen with functional in vivo validation for MRAP2/CRHR1 axis; MRAP1 interactions confirmed by multiple in vitro methods but mechanistic depth varies across GPCRs","pmids":["36314066"],"is_preprint":false},{"year":2018,"finding":"Elephant shark MRAP1 (esMrap1) co-localizes with esMc2r and esMc5r at the plasma membrane and increases their sensitivity to ACTH(1-24) 10-fold and 100-fold, respectively, without affecting surface trafficking of either receptor, demonstrating a signaling-specific (non-trafficking) function of MRAP1 in this species.","method":"Co-expression in CHO cells, fluorescence imaging (co-localization), cell surface ELISA (trafficking), cAMP stimulation assays","journal":"General and comparative endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 — ortholog study with multiple functional readouts separating trafficking from signaling effects; relevant to understanding conserved MRAP1 mechanisms","pmids":["30468718"],"is_preprint":false}],"current_model":"MRAP (melanocortin-2 receptor accessory protein) is a single-transmembrane domain protein that forms antiparallel homodimers and acts as an essential accessory protein for MC2R: it physically interacts with MC2R (and other melanocortin receptors), facilitates MC2R trafficking from the ER to the plasma membrane, and enables ACTH binding and Gs-coupled cAMP signaling—as revealed by a cryo-EM structure showing MRAP1 forms a 'seat-belt' around ACTH to stabilize MC2R activation—while also suppressing signaling of MC1R, MC3R, MC4R, and MC5R, and playing an in vivo role in adrenal progenitor cell differentiation and cortex zonation via WNT4/β-catenin and sonic hedgehog pathways."},"narrative":{"teleology":[{"year":2005,"claim":"The gene underlying familial glucocorticoid deficiency type 2 was unknown; identification of MRAP mutations in FGD2 patients and demonstration that MRAP interacts with MC2R and promotes its ER-to-surface trafficking established MRAP as a disease-causing accessory protein for the ACTH receptor.","evidence":"SNP array mapping in FGD2 families, MRAP mutation identification, MC2R interaction and trafficking assays","pmids":["15654338"],"confidence":"High","gaps":["Mechanism by which MRAP promotes MC2R trafficking not determined","Membrane topology of MRAP unknown","Whether MRAP acts on other MCRs untested"]},{"year":2007,"claim":"How MRAP is organized in the membrane was unclear; demonstration that MRAP forms antiparallel homodimers with dual topology—the first such arrangement in a eukaryotic protein—explained how a single-pass transmembrane protein can present functional domains on both sides of the membrane and form a stable complex with MC2R required for glycosylation, surface delivery, and ACTH signaling.","evidence":"Epitope-tagged topology mapping, glycosylation mutagenesis, co-IP of differentially tagged MRAPs, surface ELISA and cAMP assays in CHO and adrenal cells","pmids":["18077336"],"confidence":"High","gaps":["Atomic structure of the antiparallel dimer not resolved","Whether antiparallel arrangement is required for MC2R activation unknown"]},{"year":2008,"claim":"Whether MRAP's trafficking and signaling functions are mechanistically identical was unresolved; mutagenesis showed that a transmembrane-proximal N-terminal sequence governs dual topology, while distinct N-terminal regions are separately required for MC2R surface delivery versus ACTH binding and cAMP generation, establishing two separable MRAP functions.","evidence":"Deletion and alanine-substitution mutagenesis with surface expression, ACTH binding, and cAMP readouts","pmids":["19028547"],"confidence":"High","gaps":["Precise residues contacting MC2R versus ACTH not identified","Whether both MRAP orientations contribute equally to each function unknown"]},{"year":2009,"claim":"MRAP's specificity for MC2R was assumed; discovery that MRAP and MRAP2 interact with all five melanocortin receptors (MC1R–MC5R) and exert opposing effects—promoting MC2R signaling while suppressing MC1R/MC3R/MC4R/MC5R responsiveness—reframed MRAP as a bidirectional regulator of the entire MCR family, with receptor-specific mechanisms including differential effects on receptor dimerization and intracellular retention.","evidence":"Co-IP across all five MCRs, surface ELISA, cAMP dose-response, BiFC dimerization assays, confocal microscopy","pmids":["19329486","19535343"],"confidence":"High","gaps":["Structural basis for receptor-selective effects of MRAP unknown","In vivo relevance of MRAP suppression of non-MC2R receptors not tested"]},{"year":2018,"claim":"The in vivo consequences of MRAP loss beyond glucocorticoid deficiency were unexplored; Mrap-null mice revealed that MRAP is required for adrenal progenitor differentiation and cortex zonation through WNT4/β-catenin and sonic hedgehog pathways, and an elephant shark ortholog study showed MRAP can enhance MCR signaling sensitivity without affecting trafficking, demonstrating an evolutionarily conserved signaling-specific function.","evidence":"Mrap-knockout mouse with histology, corticosterone rescue, WNT4/SHH pathway analysis; elephant shark MRAP1 co-expression in CHO cells with surface ELISA and cAMP assays","pmids":["29879378","30468718"],"confidence":"High","gaps":["Whether MRAP directly signals to WNT4/SHH or acts indirectly through MC2R is unresolved","Whether the signaling-only mode of shark MRAP applies in mammalian tissues unknown"]},{"year":2022,"claim":"Whether MRAP acts beyond the melanocortin receptor family was unknown; a broad interaction screen identified MRAP1 interactions with 36 metabolic-related GPCRs and showed MRAP1/2 modulate their surface translocation and signaling, substantially expanding the functional scope of MRAPs.","evidence":"Single-cell transcriptomics, co-expression network analysis, protein-protein interaction and cAMP assays across 36 GPCRs, in vivo AAV-shRNA knockdown of MRAP2 in mouse hypothalamus","pmids":["36314066"],"confidence":"Medium","gaps":["Mechanistic depth for most non-MCR GPCR interactions is limited","Whether MRAP1 versus MRAP2 have distinct GPCR specificities in vivo is unclear","Physiological significance of many identified interactions not validated"]},{"year":2023,"claim":"The atomic mechanism by which MRAP enables ACTH recognition was unknown; a cryo-EM structure of the ACTH–MC2R–Gs–MRAP1 complex revealed that MRAP1 adopts a sharp extracellular kink and wraps around ACTH in a 'seat-belt' configuration, directly stabilizing ligand binding and receptor activation, with key contacts validated by mutagenesis.","evidence":"Cryo-EM structure determination of the ternary complex, mutagenesis of interface residues","pmids":["36588120"],"confidence":"High","gaps":["Structure of the MRAP antiparallel dimer without ligand/receptor not determined","How MRAP suppresses non-MC2R receptor signaling at the structural level remains unknown"]},{"year":null,"claim":"Key unresolved questions include the structural basis by which MRAP suppresses MC1R/MC3R/MC4R/MC5R signaling, whether MRAP's broader GPCR interactions are physiologically relevant beyond the melanocortin system, and how MRAP loss drives WNT4/β-catenin and SHH pathway dysregulation in adrenal progenitors.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structure of MRAP with a non-MC2R melanocortin receptor","Mechanism linking MRAP to WNT4/SHH signaling not established","In vivo tissue-specific MRAP1 versus MRAP2 functional partitioning not defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,1,2,6]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[3,4,8]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[0,1]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1,4,6]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,6,8]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[5]}],"complexes":["MC2R–MRAP1–Gs complex","MRAP antiparallel homodimer"],"partners":["MC2R","MC1R","MC3R","MC4R","MC5R","MRAP2"],"other_free_text":[]},"mechanistic_narrative":"MRAP (melanocortin-2 receptor accessory protein) is a single-transmembrane accessory protein that forms antiparallel homodimers and serves as an essential trafficking and signaling cofactor for melanocortin receptors, with broader modulatory roles across metabolic GPCRs. MRAP facilitates MC2R export from the endoplasmic reticulum to the plasma membrane and enables ACTH binding and Gs-coupled cAMP signaling through two separable functions—a trafficking function dependent on the transmembrane-proximal region and a signaling function mediated by an extracellular 'seat-belt' that wraps around ACTH to stabilize receptor activation, as revealed by cryo-EM [PMID:36588120, PMID:19028547]. While MRAP promotes MC2R surface expression and homodimerization, it suppresses signaling of MC1R, MC3R, MC4R, and MC5R, and can trap MC5R intracellularly by disrupting its dimerization, establishing MRAP as a bidirectional regulator of the melanocortin receptor family [PMID:19329486, PMID:19535343]. Loss-of-function mutations in MRAP cause familial glucocorticoid deficiency type 2, and Mrap-null mice exhibit neonatal lethality, isolated glucocorticoid deficiency, and impaired adrenal progenitor differentiation with dysregulation of WNT4/β-catenin and sonic hedgehog pathways [PMID:15654338, PMID:29879378]."},"prefetch_data":{"uniprot":{"accession":"Q8TCY5","full_name":"Melanocortin-2 receptor accessory protein","aliases":["B27","Fat cell-specific low molecular weight protein","Fat tissue-specific low MW protein"],"length_aa":172,"mass_kda":19.1,"function":"Modulator of melanocortin receptors (MC1R, MC2R, MC3R, MC4R and MC5R). Acts by increasing ligand-sensitivity of melanocortin receptors and enhancing generation of cAMP by the receptors. Required both for MC2R trafficking to the cell surface of adrenal cells and for signaling in response to corticotropin (ACTH). May be involved in the intracellular trafficking pathways in adipocyte cells","subcellular_location":"Cell membrane; Endoplasmic reticulum membrane","url":"https://www.uniprot.org/uniprotkb/Q8TCY5/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MRAP","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/MRAP","total_profiled":1310},"omim":[{"mim_id":"615410","title":"MELANOCORTIN 2 RECEPTOR ACCESSORY PROTEIN 2; MRAP2","url":"https://www.omim.org/entry/615410"},{"mim_id":"614736","title":"GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4","url":"https://www.omim.org/entry/614736"},{"mim_id":"609197","title":"GLUCOCORTICOID DEFICIENCY 3; GCCD3","url":"https://www.omim.org/entry/609197"},{"mim_id":"609196","title":"MELANOCORTIN 2 RECEPTOR ACCESSORY PROTEIN; MRAP","url":"https://www.omim.org/entry/609196"},{"mim_id":"607398","title":"GLUCOCORTICOID DEFICIENCY 2; GCCD2","url":"https://www.omim.org/entry/607398"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Endoplasmic reticulum","reliability":"Supported"},{"location":"Vesicles","reliability":"Additional"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"adipose tissue","ntpm":73.5},{"tissue":"adrenal gland","ntpm":155.2},{"tissue":"breast","ntpm":44.5}],"url":"https://www.proteinatlas.org/search/MRAP"},"hgnc":{"alias_symbol":["B27","FALP","MRAP1"],"prev_symbol":["C21orf61"]},"alphafold":{"accession":"Q8TCY5","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8TCY5","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8TCY5-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8TCY5-F1-predicted_aligned_error_v6.png","plddt_mean":58.09},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MRAP","jax_strain_url":"https://www.jax.org/strain/search?query=MRAP"},"sequence":{"accession":"Q8TCY5","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8TCY5.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8TCY5/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8TCY5"}},"corpus_meta":[{"pmid":"8377226","id":"PMC_8377226","title":"Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination.","date":"1993","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/8377226","citation_count":2032,"is_preprint":false},{"pmid":"15654338","id":"PMC_15654338","title":"Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2.","date":"2005","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15654338","citation_count":325,"is_preprint":false},{"pmid":"21248258","id":"PMC_21248258","title":"Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis.","date":"2011","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/21248258","citation_count":229,"is_preprint":false},{"pmid":"25861975","id":"PMC_25861975","title":"HLA-B27.","date":"2015","source":"Annual review of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25861975","citation_count":214,"is_preprint":false},{"pmid":"25140823","id":"PMC_25140823","title":"HLA-B27 and human β2-microglobulin affect the gut microbiota of transgenic rats.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25140823","citation_count":204,"is_preprint":false},{"pmid":"19329486","id":"PMC_19329486","title":"MRAP and MRAP2 are bidirectional regulators of the melanocortin receptor family.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19329486","citation_count":196,"is_preprint":false},{"pmid":"8473755","id":"PMC_8473755","title":"Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression.","date":"1993","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/8473755","citation_count":185,"is_preprint":false},{"pmid":"9062966","id":"PMC_9062966","title":"HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis.","date":"1997","source":"Tissue antigens","url":"https://pubmed.ncbi.nlm.nih.gov/9062966","citation_count":178,"is_preprint":false},{"pmid":"10450519","id":"PMC_10450519","title":"Inflammatory disease in HLA-B27 transgenic rats.","date":"1999","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/10450519","citation_count":160,"is_preprint":false},{"pmid":"23993278","id":"PMC_23993278","title":"HLA-B27 misfolding and ankylosing spondylitis.","date":"2013","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/23993278","citation_count":149,"is_preprint":false},{"pmid":"18077336","id":"PMC_18077336","title":"Melanocortin-2 receptor accessory protein MRAP forms antiparallel homodimers.","date":"2007","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18077336","citation_count":140,"is_preprint":false},{"pmid":"12616495","id":"PMC_12616495","title":"Lymphoblastoid cells express HLA-B27 homodimers both intracellularly and at the cell surface following endosomal recycling.","date":"2003","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12616495","citation_count":137,"is_preprint":false},{"pmid":"2679637","id":"PMC_2679637","title":"HLA-B27 and HLA-A2 subtypes: structure, evolution and function.","date":"1989","source":"Immunology today","url":"https://pubmed.ncbi.nlm.nih.gov/2679637","citation_count":129,"is_preprint":false},{"pmid":"11698424","id":"PMC_11698424","title":"Leukocyte receptor complex-encoded immunomodulatory receptors show differing specificity for alternative HLA-B27 structures.","date":"2001","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11698424","citation_count":129,"is_preprint":false},{"pmid":"20193000","id":"PMC_20193000","title":"From HLA-B27 to spondyloarthritis: a journey through the ER.","date":"2010","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/20193000","citation_count":126,"is_preprint":false},{"pmid":"14734527","id":"PMC_14734527","title":"Dual, HLA-B27 subtype-dependent conformation of a self-peptide.","date":"2004","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/14734527","citation_count":114,"is_preprint":false},{"pmid":"2126195","id":"PMC_2126195","title":"Structural homologies between two HLA B27-restricted peptides suggest residues important for interaction with HLA B27.","date":"1990","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/2126195","citation_count":108,"is_preprint":false},{"pmid":"15265899","id":"PMC_15265899","title":"HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors.","date":"2004","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/15265899","citation_count":102,"is_preprint":false},{"pmid":"6418259","id":"PMC_6418259","title":"The cross-tolerance hypothesis, HLA-B27 and ankylosing spondylitis.","date":"1983","source":"British journal of rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/6418259","citation_count":102,"is_preprint":false},{"pmid":"30301938","id":"PMC_30301938","title":"The microbiome and HLA-B27-associated acute anterior uveitis.","date":"2018","source":"Nature reviews. Rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/30301938","citation_count":101,"is_preprint":false},{"pmid":"19565478","id":"PMC_19565478","title":"Spondylarthritis in HLA-B27/human beta2-microglobulin-transgenic rats is not prevented by lack of CD8.","date":"2009","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/19565478","citation_count":100,"is_preprint":false},{"pmid":"17289555","id":"PMC_17289555","title":"The pathogenetic role of HLA-B27 and its subtypes.","date":"2006","source":"Autoimmunity reviews","url":"https://pubmed.ncbi.nlm.nih.gov/17289555","citation_count":98,"is_preprint":false},{"pmid":"11555726","id":"PMC_11555726","title":"HLA-B27 and genetic predisposing factors in spondyloarthropathies.","date":"2001","source":"Current opinion in rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/11555726","citation_count":96,"is_preprint":false},{"pmid":"17407096","id":"PMC_17407096","title":"Interaction of HLA-B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 heterotrimers, is independent of the sequence of bound peptide.","date":"2007","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/17407096","citation_count":94,"is_preprint":false},{"pmid":"6607143","id":"PMC_6607143","title":"HLA-B27 and the immune response to enterobacterial antigens in ankylosing spondylitis.","date":"1984","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/6607143","citation_count":93,"is_preprint":false},{"pmid":"19028547","id":"PMC_19028547","title":"Structure and function of the melanocortin2 receptor accessory protein (MRAP).","date":"2008","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/19028547","citation_count":84,"is_preprint":false},{"pmid":"29287307","id":"PMC_29287307","title":"Effects of HLA-B27 on Gut Microbiota in Experimental Spondyloarthritis Implicate an Ecological Model of Dysbiosis.","date":"2018","source":"Arthritis & rheumatology (Hoboken, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/29287307","citation_count":82,"is_preprint":false},{"pmid":"14684742","id":"PMC_14684742","title":"Formation of HLA-B27 homodimers and their relationship to assembly kinetics.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14684742","citation_count":82,"is_preprint":false},{"pmid":"19535343","id":"PMC_19535343","title":"Opposite effects of the melanocortin-2 (MC2) receptor accessory protein MRAP on MC2 and MC5 receptor dimerization and trafficking.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19535343","citation_count":75,"is_preprint":false},{"pmid":"1588045","id":"PMC_1588045","title":"HLA-B27 expression modulates gram-negative bacterial invasion into transfected L cells.","date":"1992","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/1588045","citation_count":74,"is_preprint":false},{"pmid":"10754261","id":"PMC_10754261","title":"Survival of hippocampal and cortical neurons in a mixture of MEM+ and B27-supplemented neurobasal medium.","date":"2000","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/10754261","citation_count":72,"is_preprint":false},{"pmid":"12077714","id":"PMC_12077714","title":"Psoriatic spondyloarthropathy: a comparative study between HLA-B27 positive and HLA-B27 negative disease.","date":"2002","source":"Seminars in arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/12077714","citation_count":70,"is_preprint":false},{"pmid":"23990399","id":"PMC_23990399","title":"Polymorphism of HLA-B27: 105 subtypes currently known.","date":"2013","source":"Current rheumatology reports","url":"https://pubmed.ncbi.nlm.nih.gov/23990399","citation_count":69,"is_preprint":false},{"pmid":"12122005","id":"PMC_12122005","title":"Molecular mimicry of an HLA-B27-derived ligand of arthritis-linked subtypes with chlamydial proteins.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12122005","citation_count":66,"is_preprint":false},{"pmid":"12468816","id":"PMC_12468816","title":"Increased level of HLA-B27 expression in ankylosing spondylitis patients compared with healthy HLA-B27-positive subjects: a possible further susceptibility factor for the development of disease.","date":"2002","source":"Rheumatology (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/12468816","citation_count":66,"is_preprint":false},{"pmid":"10602882","id":"PMC_10602882","title":"The role of HLA-B27 in spondyloarthritis.","date":"1999","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/10602882","citation_count":59,"is_preprint":false},{"pmid":"33469457","id":"PMC_33469457","title":"Recent Developments in HLA B27 Anterior Uveitis.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33469457","citation_count":59,"is_preprint":false},{"pmid":"12154202","id":"PMC_12154202","title":"HLA B27 in health and disease: a double-edged sword?","date":"2002","source":"Rheumatology (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/12154202","citation_count":58,"is_preprint":false},{"pmid":"93049","id":"PMC_93049","title":"HLA B27 and defects in the T-cell system in Whipple's disease.","date":"1979","source":"European journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/93049","citation_count":57,"is_preprint":false},{"pmid":"26289052","id":"PMC_26289052","title":"HLA-B27 and psoriatic disease: a modern view of an old relationship.","date":"2015","source":"Rheumatology (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/26289052","citation_count":56,"is_preprint":false},{"pmid":"21428748","id":"PMC_21428748","title":"An update on the genetics of HLA B27-associated acute anterior uveitis.","date":"2011","source":"Ocular immunology and inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/21428748","citation_count":55,"is_preprint":false},{"pmid":"17129613","id":"PMC_17129613","title":"HLA-B27 and the pathogenesis of spondyloarthropathies.","date":"2006","source":"Immunology letters","url":"https://pubmed.ncbi.nlm.nih.gov/17129613","citation_count":52,"is_preprint":false},{"pmid":"2672931","id":"PMC_2672931","title":"Molecular mimicry in HLA-B27-related arthritis.","date":"1989","source":"Annals of internal medicine","url":"https://pubmed.ncbi.nlm.nih.gov/2672931","citation_count":52,"is_preprint":false},{"pmid":"28759104","id":"PMC_28759104","title":"The interplay between HLA-B27 and ERAP1/ERAP2 aminopeptidases: from anti-viral protection to spondyloarthritis.","date":"2017","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/28759104","citation_count":50,"is_preprint":false},{"pmid":"21296192","id":"PMC_21296192","title":"What is the role of HLA-B27 in spondyloarthropathies?","date":"2011","source":"Autoimmunity reviews","url":"https://pubmed.ncbi.nlm.nih.gov/21296192","citation_count":49,"is_preprint":false},{"pmid":"15011956","id":"PMC_15011956","title":"The immunobiology of HLA-B27: variations on a theme.","date":"2004","source":"Current molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15011956","citation_count":48,"is_preprint":false},{"pmid":"35818337","id":"PMC_35818337","title":"Both Disease Activity and HLA-B27 Status Are Associated With Gut Microbiome Dysbiosis in Spondyloarthritis Patients.","date":"2022","source":"Arthritis & rheumatology (Hoboken, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/35818337","citation_count":48,"is_preprint":false},{"pmid":"21123333","id":"PMC_21123333","title":"The role of HLA-B27 in spondyloarthritis.","date":"2010","source":"The Journal of rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/21123333","citation_count":46,"is_preprint":false},{"pmid":"18489433","id":"PMC_18489433","title":"Peptides: the cornerstone of HLA-B27 biology and pathogenetic role in spondyloarthritis.","date":"2008","source":"Tissue antigens","url":"https://pubmed.ncbi.nlm.nih.gov/18489433","citation_count":46,"is_preprint":false},{"pmid":"22674414","id":"PMC_22674414","title":"Expression of HLA-B27 causes loss of migratory dendritic cells in a rat model of spondylarthritis.","date":"2012","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/22674414","citation_count":46,"is_preprint":false},{"pmid":"17469106","id":"PMC_17469106","title":"Alteration of antigen-independent immunologic synapse formation between dendritic cells from HLA-B27-transgenic rats and CD4+ T cells: selective impairment of costimulatory molecule engagement by mature HLA-B27.","date":"2007","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/17469106","citation_count":45,"is_preprint":false},{"pmid":"20083539","id":"PMC_20083539","title":"HLA-B27: what's new?","date":"2010","source":"Rheumatology (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/20083539","citation_count":43,"is_preprint":false},{"pmid":"30355574","id":"PMC_30355574","title":"Salmonella exploits HLA-B27 and host unfolded protein responses to promote intracellular replication.","date":"2018","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/30355574","citation_count":41,"is_preprint":false},{"pmid":"107868","id":"PMC_107868","title":"HLA B27 and the genetics of ankylosing spondylitis.","date":"1978","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/107868","citation_count":41,"is_preprint":false},{"pmid":"32679290","id":"PMC_32679290","title":"Emerging roles of melanocortin receptor accessory proteins (MRAP and MRAP2) in physiology and pathophysiology.","date":"2020","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/32679290","citation_count":38,"is_preprint":false},{"pmid":"19731628","id":"PMC_19731628","title":"Subtypes of HLA-B27: history and implications in the pathogenesis of ankylosing spondylitis.","date":"2009","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/19731628","citation_count":38,"is_preprint":false},{"pmid":"55536","id":"PMC_55536","title":"HLA-B27 and modified bone formation.","date":"1976","source":"Lancet (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/55536","citation_count":37,"is_preprint":false},{"pmid":"15011957","id":"PMC_15011957","title":"Animal models of HLA-B27-associated diseases.","date":"2004","source":"Current molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15011957","citation_count":36,"is_preprint":false},{"pmid":"36197645","id":"PMC_36197645","title":"T cell Repertoire Profiling and the Mechanism by which HLA-B27 Causes Ankylosing Spondylitis.","date":"2022","source":"Current rheumatology reports","url":"https://pubmed.ncbi.nlm.nih.gov/36197645","citation_count":36,"is_preprint":false},{"pmid":"12110134","id":"PMC_12110134","title":"HLA-B27: natural function and pathogenic role in spondyloarthritis.","date":"2002","source":"Arthritis research","url":"https://pubmed.ncbi.nlm.nih.gov/12110134","citation_count":36,"is_preprint":false},{"pmid":"1689355","id":"PMC_1689355","title":"In vitro mutagenesis of HLA-B27. Amino acid substitutions at position 67 disrupt anti-B27 monoclonal antibody binding in direct relation to the size of the substituted side chain.","date":"1990","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/1689355","citation_count":36,"is_preprint":false},{"pmid":"7510742","id":"PMC_7510742","title":"Unusual topology of an HLA-B27 allospecific T cell epitope lacking peptide specificity.","date":"1994","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/7510742","citation_count":36,"is_preprint":false},{"pmid":"2783451","id":"PMC_2783451","title":"Lack of expression of HLA-B27 gene in transgenic mouse trophoblast. Conserved genetic pressures underlying extra-embryonic development.","date":"1989","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/2783451","citation_count":36,"is_preprint":false},{"pmid":"15011960","id":"PMC_15011960","title":"Recognition of classical and heavy chain forms of HLA-B27 by leukocyte receptors.","date":"2004","source":"Current molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15011960","citation_count":35,"is_preprint":false},{"pmid":"19363299","id":"PMC_19363299","title":"HLA-B27 misfolding and spondyloarthropathies.","date":"2009","source":"Prion","url":"https://pubmed.ncbi.nlm.nih.gov/19363299","citation_count":34,"is_preprint":false},{"pmid":"6608924","id":"PMC_6608924","title":"Polymorphonuclear cell motility, ankylosing spondylitis, and HLA B27.","date":"1984","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/6608924","citation_count":34,"is_preprint":false},{"pmid":"27245590","id":"PMC_27245590","title":"HLA-B27 Anterior Uveitis: Immunology and Immunopathology.","date":"2016","source":"Ocular immunology and inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/27245590","citation_count":33,"is_preprint":false},{"pmid":"23916069","id":"PMC_23916069","title":"HLA-B27 and antigen presentation: at the crossroads between immune defense and autoimmunity.","date":"2013","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/23916069","citation_count":33,"is_preprint":false},{"pmid":"7523137","id":"PMC_7523137","title":"Identification of T cell receptor recognition residues for a viral peptide presented by HLA B27.","date":"1994","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/7523137","citation_count":33,"is_preprint":false},{"pmid":"19617632","id":"PMC_19617632","title":"Structural basis for T cell alloreactivity among three HLA-B14 and HLA-B27 antigens.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19617632","citation_count":33,"is_preprint":false},{"pmid":"10491358","id":"PMC_10491358","title":"HLA-B27 associated spondyloarthropathy, an autoimmune disease based on crossreactivity between bacteria and HLA-B27?","date":"1999","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/10491358","citation_count":32,"is_preprint":false},{"pmid":"8835495","id":"PMC_8835495","title":"Seronegative spondyloarthropathies and HLA-B27 subtyes: a study in Asian Indians.","date":"1996","source":"Clinical rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/8835495","citation_count":32,"is_preprint":false},{"pmid":"16868047","id":"PMC_16868047","title":"Unusual presentation of familial glucocorticoid deficiency with a novel MRAP mutation.","date":"2006","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/16868047","citation_count":29,"is_preprint":false},{"pmid":"34783307","id":"PMC_34783307","title":"Intraocular dendritic cells characterize HLA-B27-associated acute anterior uveitis.","date":"2021","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/34783307","citation_count":28,"is_preprint":false},{"pmid":"29342507","id":"PMC_29342507","title":"The Role of Autophagy in the Degradation of Misfolded HLA-B27 Heavy Chains.","date":"2018","source":"Arthritis & rheumatology (Hoboken, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/29342507","citation_count":28,"is_preprint":false},{"pmid":"2259879","id":"PMC_2259879","title":"B27+ disease versus B27- disease.","date":"1990","source":"Scandinavian journal of rheumatology. Supplement","url":"https://pubmed.ncbi.nlm.nih.gov/2259879","citation_count":27,"is_preprint":false},{"pmid":"19731637","id":"PMC_19731637","title":"The role of B27 heavy chain dimer immune receptor interactions in spondyloarthritis.","date":"2009","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/19731637","citation_count":27,"is_preprint":false},{"pmid":"7860357","id":"PMC_7860357","title":"Molecular analysis of HLA-B27 haplotypes in Caucasoids. Frequencies of B27-Cw in Jewish and Spanish populations.","date":"1994","source":"Human immunology","url":"https://pubmed.ncbi.nlm.nih.gov/7860357","citation_count":27,"is_preprint":false},{"pmid":"30468718","id":"PMC_30468718","title":"Elephant shark melanocortin receptors: Novel interactions with MRAP1 and implication for the HPI axis.","date":"2018","source":"General and comparative endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/30468718","citation_count":26,"is_preprint":false},{"pmid":"29879378","id":"PMC_29879378","title":"MRAP deficiency impairs adrenal progenitor cell differentiation and gland zonation.","date":"2018","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/29879378","citation_count":25,"is_preprint":false},{"pmid":"19731632","id":"PMC_19731632","title":"HLA-B27 misfolding and spondyloarthropathies.","date":"2009","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/19731632","citation_count":25,"is_preprint":false},{"pmid":"8864580","id":"PMC_8864580","title":"HLA-B27 structure, function, and disease association.","date":"1996","source":"Current opinion in rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/8864580","citation_count":25,"is_preprint":false},{"pmid":"24692163","id":"PMC_24692163","title":"HLA-B27 subtype oligomerization and intracellular accumulation patterns correlate with predisposition to spondyloarthritis.","date":"2014","source":"Arthritis & rheumatology (Hoboken, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/24692163","citation_count":25,"is_preprint":false},{"pmid":"23666508","id":"PMC_23666508","title":"HLA-B27 alters the response to tumor necrosis factor α and promotes osteoclastogenesis in bone marrow monocytes from HLA-B27-transgenic rats.","date":"2013","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/23666508","citation_count":25,"is_preprint":false},{"pmid":"36588120","id":"PMC_36588120","title":"Structural basis of signaling regulation of the human melanocortin-2 receptor by MRAP1.","date":"2023","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/36588120","citation_count":24,"is_preprint":false},{"pmid":"1555037","id":"PMC_1555037","title":"Molecular mimicry in the pathogenesis of spondyloarthropathies. A critical appraisal of cross-reactivity between microbial antigens and HLA-B27.","date":"1992","source":"British journal of rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/1555037","citation_count":24,"is_preprint":false},{"pmid":"19731629","id":"PMC_19731629","title":"Implications of structural and thermodynamic studies of HLA-B27 subtypes exhibiting differential association with ankylosing spondylitis.","date":"2009","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/19731629","citation_count":24,"is_preprint":false},{"pmid":"9007822","id":"PMC_9007822","title":"The influence of HLA B27 and interferon-gamma on the invasion and persistence of yersinia in primary human fibroblasts.","date":"1996","source":"Medical microbiology and immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9007822","citation_count":24,"is_preprint":false},{"pmid":"37679034","id":"PMC_37679034","title":"HLA-B27, axial spondyloarthritis and survival.","date":"2023","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/37679034","citation_count":23,"is_preprint":false},{"pmid":"27002532","id":"PMC_27002532","title":"Does the Microbiome Cause B27-related Acute Anterior Uveitis?","date":"2016","source":"Ocular immunology and inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/27002532","citation_count":23,"is_preprint":false},{"pmid":"24835397","id":"PMC_24835397","title":"HLA-B27, but not HLA-B7, immunodominance to influenza is ERAP dependent.","date":"2014","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/24835397","citation_count":23,"is_preprint":false},{"pmid":"27036372","id":"PMC_27036372","title":"Non-conventional forms of HLA-B27 are expressed in spondyloarthritis joints and gut tissue.","date":"2016","source":"Journal of autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/27036372","citation_count":23,"is_preprint":false},{"pmid":"18079713","id":"PMC_18079713","title":"Profiling of microRNA expression by mRAP.","date":"2007","source":"Nature protocols","url":"https://pubmed.ncbi.nlm.nih.gov/18079713","citation_count":22,"is_preprint":false},{"pmid":"23910730","id":"PMC_23910730","title":"The biochemistry and immunology of non-canonical forms of HLA-B27.","date":"2013","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/23910730","citation_count":21,"is_preprint":false},{"pmid":"2212952","id":"PMC_2212952","title":"Expression of HLA-B27 in transgenic mice is dependent on the mouse H-2D genes.","date":"1990","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/2212952","citation_count":21,"is_preprint":false},{"pmid":"14719206","id":"PMC_14719206","title":"Undifferentiated spondyloarthropathies in Brazilians: importance of HLA-B27 and the B7-CREG alleles in characterization and disease progression.","date":"2003","source":"The Journal of rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/14719206","citation_count":21,"is_preprint":false},{"pmid":"36314066","id":"PMC_36314066","title":"Identification of MRAP protein family as broad-spectrum GPCR modulators.","date":"2022","source":"Clinical and translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36314066","citation_count":20,"is_preprint":false},{"pmid":"29849482","id":"PMC_29849482","title":"Influence of TNF and IL17 Gene Polymorphisms on the Spondyloarthritis Immunopathogenesis, Regardless of HLA-B27, in a Brazilian Population.","date":"2018","source":"Mediators of inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/29849482","citation_count":20,"is_preprint":false},{"pmid":"10910175","id":"PMC_10910175","title":"HLA-B27 and immunogenetics of spondyloarthropathies.","date":"2000","source":"Current opinion in rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/10910175","citation_count":19,"is_preprint":false},{"pmid":"10723676","id":"PMC_10723676","title":"Colitis in HLA-B27/beta 2 microglobulin transgenic rats.","date":"2000","source":"International reviews of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10723676","citation_count":19,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":47541,"output_tokens":2788,"usd":0.092221},"stage2":{"model":"claude-opus-4-6","input_tokens":6126,"output_tokens":2517,"usd":0.140332},"total_usd":0.232553,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2005,\n      \"finding\": \"MRAP (melanocortin 2 receptor accessory protein) was identified as an interacting partner of the ACTH receptor (MC2R); mutations in MRAP cause familial glucocorticoid deficiency type 2, and MRAP was shown to interact with MC2R and have a role in trafficking MC2R from the endoplasmic reticulum to the cell surface.\",\n      \"method\": \"SNP array genotyping (disease mapping), identification of MRAP mutations in FGD2 patients, interaction studies between MRAP and MC2R\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — foundational discovery paper with genetic mapping plus direct interaction and trafficking data, highly cited\",\n      \"pmids\": [\"15654338\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"MRAP forms antiparallel homodimers with a unique dual topology: both N- and C-terminal ends of MRAP face the extracellular side. MRAP homodimers form a stable complex with MC2R at the plasma membrane and are required for MC2R glycosylation, surface localization, and ACTH-stimulated cAMP signaling; without MRAP, MC2R is retained in the endoplasmic reticulum.\",\n      \"method\": \"Epitope localization with N- and C-terminal antibodies in CHO and adrenal cells, glycosylation mutagenesis to probe membrane topology, co-immunoprecipitation of differentially tagged MRAPs, selective immunoprecipitation of cell-surface MRAP, ELISA and cAMP assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal methods (topology assay, glycosylation mutagenesis, co-IP, functional cAMP assay) in a single rigorous study; first eukaryotic antiparallel homodimer identified\",\n      \"pmids\": [\"18077336\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"A short sequence just N-terminal to the transmembrane domain of MRAP is essential for its dual membrane topology; the transmembrane region alone is not sufficient. Deletion or alanine substitution of other N-terminal regions yields MRAP mutants that promote MC2R surface expression but not ACTH binding or receptor signaling, establishing two separable functions of MRAP: (1) facilitating MC2R trafficking and (2) enabling surface receptor binding and cAMP signaling.\",\n      \"method\": \"Deletion and alanine-substitution mutagenesis of MRAP, surface expression assays, ACTH binding assays, cAMP stimulation assays\",\n      \"journal\": \"Molecular and cellular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis with multiple functional readouts (trafficking vs. signaling) dissecting two mechanistically distinct MRAP activities\",\n      \"pmids\": [\"19028547\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"MRAP and its homologue MRAP2 interact with all five melanocortin receptors (MC1R–MC5R). MRAP/MRAP2 interaction with MC2R promotes surface expression and cAMP signaling, while interaction with MC1R, MC3R, MC4R, and MC5R reduces their responsiveness to NDP-MSH, establishing MRAP and MRAP2 as bidirectional regulators of the MCR family.\",\n      \"method\": \"Co-immunoprecipitation, surface expression assays (ELISA), cAMP signaling assays, NDP-MSH dose-response experiments in transfected cells\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal interaction and functional signaling data across all 5 MCRs with multiple orthogonal methods\",\n      \"pmids\": [\"19329486\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"MRAP has opposite effects on MC2R versus MC5R: MRAP promotes MC2R surface expression and traps MC5R intracellularly. MRAP forms stable complexes with both receptors (co-precipitation). MRAP facilitates MC2R homodimerization at the plasma membrane but disrupts MC5R dimerization intracellularly. The regions of MRAP required for effects on MC2R and MC5R differ.\",\n      \"method\": \"ELISA surface expression assay, confocal microscopy, bimolecular fluorescence complementation (BiFC) for receptor dimerization, co-immunoprecipitation of differentially tagged receptors\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (BiFC, co-IP, ELISA, microscopy) demonstrating mechanistically distinct receptor-specific effects of MRAP\",\n      \"pmids\": [\"19535343\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"MRAP deficiency in mice causes neonatal lethality (rescued by maternal corticosterone), isolated glucocorticoid deficiency with normal mineralocorticoid and catecholamine production, small adrenal glands with impaired capsular morphology and cortex zonation, and significantly impaired adrenal progenitor cell differentiation with dysregulation of WNT4/β-catenin and sonic hedgehog pathways.\",\n      \"method\": \"Mrap-null mouse generation, histology, corticosterone rescue, WNT4/β-catenin and sonic hedgehog pathway analysis in knockout adrenal glands\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean knockout model with specific adrenal phenotype and pathway placement (WNT4/SHH), replicated by multiple readouts\",\n      \"pmids\": [\"29879378\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Cryo-EM structure of ACTH-bound MC2R–Gs–MRAP1 complex reveals that MRAP1 has a unique sharp kink at its extracellular region and exerts a 'seat-belt' effect that stabilizes ACTH binding and MC2R activation; mutagenesis validated key contact residues.\",\n      \"method\": \"Cryo-electron microscopy structure determination, mutagenesis analysis of MRAP1–MC2R interface\",\n      \"journal\": \"Cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — atomic-resolution cryo-EM structure plus mutagenesis validation, directly revealing the molecular mechanism of MRAP1 action on MC2R\",\n      \"pmids\": [\"36588120\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"A novel 7-base deletion in exon 3 of MRAP causing a frameshift and premature stop codon (L31X) was identified in patients with familial glucocorticoid deficiency type 2, confirming that loss-of-function MRAP mutations cause FGD2.\",\n      \"method\": \"DNA sequencing of MRAP gene in patient fibroblasts and peripheral blood, identification of homozygous frameshift mutation\",\n      \"journal\": \"The Journal of clinical endocrinology and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — genetic loss-of-function finding with clinical phenotype, single report confirming MRAP mutation mechanism in FGD2\",\n      \"pmids\": [\"16868047\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MRAP1 interacts with a broad spectrum of GPCRs beyond melanocortin receptors. Protein-protein interactions of MRAP1 with 36 metabolic-related GPCRs were identified; MRAP1/2 modulate surface translocation, constitutive activities, and ligand-stimulated downstream signaling of these GPCRs. Hypothalamic MRAP2 knockdown via AAV-shRNA stimulated body weight gain, and MRAP2 was required for the anorectic effect of CRF acting through CRHR1.\",\n      \"method\": \"Single-cell transcriptome analysis, co-expression network analysis, protein-protein interaction assays, cell surface translocation assays, cAMP signaling assays, AAV-shRNA knockdown in mouse hypothalamus with body weight and feeding behavior readouts\",\n      \"journal\": \"Clinical and translational medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — broad interactome screen with functional in vivo validation for MRAP2/CRHR1 axis; MRAP1 interactions confirmed by multiple in vitro methods but mechanistic depth varies across GPCRs\",\n      \"pmids\": [\"36314066\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Elephant shark MRAP1 (esMrap1) co-localizes with esMc2r and esMc5r at the plasma membrane and increases their sensitivity to ACTH(1-24) 10-fold and 100-fold, respectively, without affecting surface trafficking of either receptor, demonstrating a signaling-specific (non-trafficking) function of MRAP1 in this species.\",\n      \"method\": \"Co-expression in CHO cells, fluorescence imaging (co-localization), cell surface ELISA (trafficking), cAMP stimulation assays\",\n      \"journal\": \"General and comparative endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ortholog study with multiple functional readouts separating trafficking from signaling effects; relevant to understanding conserved MRAP1 mechanisms\",\n      \"pmids\": [\"30468718\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MRAP (melanocortin-2 receptor accessory protein) is a single-transmembrane domain protein that forms antiparallel homodimers and acts as an essential accessory protein for MC2R: it physically interacts with MC2R (and other melanocortin receptors), facilitates MC2R trafficking from the ER to the plasma membrane, and enables ACTH binding and Gs-coupled cAMP signaling—as revealed by a cryo-EM structure showing MRAP1 forms a 'seat-belt' around ACTH to stabilize MC2R activation—while also suppressing signaling of MC1R, MC3R, MC4R, and MC5R, and playing an in vivo role in adrenal progenitor cell differentiation and cortex zonation via WNT4/β-catenin and sonic hedgehog pathways.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"MRAP (melanocortin-2 receptor accessory protein) is a single-transmembrane accessory protein that forms antiparallel homodimers and serves as an essential trafficking and signaling cofactor for melanocortin receptors, with broader modulatory roles across metabolic GPCRs. MRAP facilitates MC2R export from the endoplasmic reticulum to the plasma membrane and enables ACTH binding and Gs-coupled cAMP signaling through two separable functions—a trafficking function dependent on the transmembrane-proximal region and a signaling function mediated by an extracellular 'seat-belt' that wraps around ACTH to stabilize receptor activation, as revealed by cryo-EM [PMID:36588120, PMID:19028547]. While MRAP promotes MC2R surface expression and homodimerization, it suppresses signaling of MC1R, MC3R, MC4R, and MC5R, and can trap MC5R intracellularly by disrupting its dimerization, establishing MRAP as a bidirectional regulator of the melanocortin receptor family [PMID:19329486, PMID:19535343]. Loss-of-function mutations in MRAP cause familial glucocorticoid deficiency type 2, and Mrap-null mice exhibit neonatal lethality, isolated glucocorticoid deficiency, and impaired adrenal progenitor differentiation with dysregulation of WNT4/β-catenin and sonic hedgehog pathways [PMID:15654338, PMID:29879378].\",\n  \"teleology\": [\n    {\n      \"year\": 2005,\n      \"claim\": \"The gene underlying familial glucocorticoid deficiency type 2 was unknown; identification of MRAP mutations in FGD2 patients and demonstration that MRAP interacts with MC2R and promotes its ER-to-surface trafficking established MRAP as a disease-causing accessory protein for the ACTH receptor.\",\n      \"evidence\": \"SNP array mapping in FGD2 families, MRAP mutation identification, MC2R interaction and trafficking assays\",\n      \"pmids\": [\"15654338\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which MRAP promotes MC2R trafficking not determined\", \"Membrane topology of MRAP unknown\", \"Whether MRAP acts on other MCRs untested\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"How MRAP is organized in the membrane was unclear; demonstration that MRAP forms antiparallel homodimers with dual topology—the first such arrangement in a eukaryotic protein—explained how a single-pass transmembrane protein can present functional domains on both sides of the membrane and form a stable complex with MC2R required for glycosylation, surface delivery, and ACTH signaling.\",\n      \"evidence\": \"Epitope-tagged topology mapping, glycosylation mutagenesis, co-IP of differentially tagged MRAPs, surface ELISA and cAMP assays in CHO and adrenal cells\",\n      \"pmids\": [\"18077336\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic structure of the antiparallel dimer not resolved\", \"Whether antiparallel arrangement is required for MC2R activation unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Whether MRAP's trafficking and signaling functions are mechanistically identical was unresolved; mutagenesis showed that a transmembrane-proximal N-terminal sequence governs dual topology, while distinct N-terminal regions are separately required for MC2R surface delivery versus ACTH binding and cAMP generation, establishing two separable MRAP functions.\",\n      \"evidence\": \"Deletion and alanine-substitution mutagenesis with surface expression, ACTH binding, and cAMP readouts\",\n      \"pmids\": [\"19028547\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise residues contacting MC2R versus ACTH not identified\", \"Whether both MRAP orientations contribute equally to each function unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"MRAP's specificity for MC2R was assumed; discovery that MRAP and MRAP2 interact with all five melanocortin receptors (MC1R–MC5R) and exert opposing effects—promoting MC2R signaling while suppressing MC1R/MC3R/MC4R/MC5R responsiveness—reframed MRAP as a bidirectional regulator of the entire MCR family, with receptor-specific mechanisms including differential effects on receptor dimerization and intracellular retention.\",\n      \"evidence\": \"Co-IP across all five MCRs, surface ELISA, cAMP dose-response, BiFC dimerization assays, confocal microscopy\",\n      \"pmids\": [\"19329486\", \"19535343\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for receptor-selective effects of MRAP unknown\", \"In vivo relevance of MRAP suppression of non-MC2R receptors not tested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"The in vivo consequences of MRAP loss beyond glucocorticoid deficiency were unexplored; Mrap-null mice revealed that MRAP is required for adrenal progenitor differentiation and cortex zonation through WNT4/β-catenin and sonic hedgehog pathways, and an elephant shark ortholog study showed MRAP can enhance MCR signaling sensitivity without affecting trafficking, demonstrating an evolutionarily conserved signaling-specific function.\",\n      \"evidence\": \"Mrap-knockout mouse with histology, corticosterone rescue, WNT4/SHH pathway analysis; elephant shark MRAP1 co-expression in CHO cells with surface ELISA and cAMP assays\",\n      \"pmids\": [\"29879378\", \"30468718\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether MRAP directly signals to WNT4/SHH or acts indirectly through MC2R is unresolved\", \"Whether the signaling-only mode of shark MRAP applies in mammalian tissues unknown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Whether MRAP acts beyond the melanocortin receptor family was unknown; a broad interaction screen identified MRAP1 interactions with 36 metabolic-related GPCRs and showed MRAP1/2 modulate their surface translocation and signaling, substantially expanding the functional scope of MRAPs.\",\n      \"evidence\": \"Single-cell transcriptomics, co-expression network analysis, protein-protein interaction and cAMP assays across 36 GPCRs, in vivo AAV-shRNA knockdown of MRAP2 in mouse hypothalamus\",\n      \"pmids\": [\"36314066\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanistic depth for most non-MCR GPCR interactions is limited\", \"Whether MRAP1 versus MRAP2 have distinct GPCR specificities in vivo is unclear\", \"Physiological significance of many identified interactions not validated\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"The atomic mechanism by which MRAP enables ACTH recognition was unknown; a cryo-EM structure of the ACTH–MC2R–Gs–MRAP1 complex revealed that MRAP1 adopts a sharp extracellular kink and wraps around ACTH in a 'seat-belt' configuration, directly stabilizing ligand binding and receptor activation, with key contacts validated by mutagenesis.\",\n      \"evidence\": \"Cryo-EM structure determination of the ternary complex, mutagenesis of interface residues\",\n      \"pmids\": [\"36588120\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure of the MRAP antiparallel dimer without ligand/receptor not determined\", \"How MRAP suppresses non-MC2R receptor signaling at the structural level remains unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis by which MRAP suppresses MC1R/MC3R/MC4R/MC5R signaling, whether MRAP's broader GPCR interactions are physiologically relevant beyond the melanocortin system, and how MRAP loss drives WNT4/β-catenin and SHH pathway dysregulation in adrenal progenitors.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structure of MRAP with a non-MC2R melanocortin receptor\", \"Mechanism linking MRAP to WNT4/SHH signaling not established\", \"In vivo tissue-specific MRAP1 versus MRAP2 functional partitioning not defined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 1, 2, 6]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [3, 4, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1, 4, 6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0009609507\", \"supporting_discovery_ids\": [0, 1, 2, 4]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 6, 8]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"complexes\": [\n      \"MC2R–MRAP1–Gs complex\",\n      \"MRAP antiparallel homodimer\"\n    ],\n    \"partners\": [\n      \"MC2R\",\n      \"MC1R\",\n      \"MC3R\",\n      \"MC4R\",\n      \"MC5R\",\n      \"MRAP2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}